Impact of access to hospitals with catheterization facilities in the second Gulf Registry of Acute Coronary Events (Gulf RACE-2)

Coronary Artery Disease

Volumn 24, Issue 5, 2013, Pages 412-418

  Alhabib, Khalid F ^a   Jolly, Sanjit S ^d   Yusuf, Salim ^d   Alsheikh Ali, Alawi A ^e,f   Al Suwaidi, Jassim ^g   Hersi, Ahmad ^a   Sulaiman, Kadhim ^h   Al Saif, Shukri ^c   Almahmeed, Wael ⁱ   Asaad, Nidal ^g   Amin, Haitham ^j   Al Motarreb, Ahmed ^k   Alfaleh, Hussam ^a   Alnemer, Khalid ^b   Thalib, Lukman ^l  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b SECURITY FORCES HOSPITAL   (Saudi Arabia)

^c Saud Al Babtain Cardiac Hospital   (Saudi Arabia)

^d MCMASTER UNIVERSITY   (Canada)

^e Institute of Cardiac Sciences   (United Arab Emirates)

^f Department of Cardiology ^*  (United Arab Emirates)

^g TUFTS MEDICAL CENTER   (United States)

^h HAMAD MEDICAL CORPORATION   (Qatar)

ⁱ ROYAL HOSPITAL   (Oman)

^j BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

^k University of Sana   (Yemen)

^l KUWAIT UNIVERSITY   (Kuwait)

more..

Author keywords

acute coronary syndrome; catheterization facilities; coronary artery disease; middle east; percutaneous coronary intervention

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION;

EID: 84880772713     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328361a910     Document Type: Article

References (23)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20.
2. [No authors listed]. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Fragmin and fast revascularization during instability in coronary artery disease investigators. Lancet 1999; 354:708-715.
3. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879-1887.
4. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomised intervention trial of unstable angina. Lancet 2002; 360:743-751.
5. Brophy JM, Bogaty P. Primary angioplasty and thrombolysis are both reasonable options in acute myocardial infarction. Ann Intern Med 2004; 141:292-297.
6. Van deWerf F, Gore JM, Avezum A, Gulba DC, Goodman SG, Budaj A, et al. GRACE Investigators. Access to catheterization facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ 2005; 330:441.
7. Every NR, Larson EB, Litwin PE, Maynard C, Fihn SD, Eisenberg MS, et al. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993; 329:546-551.
8. Alhabib KF, Sulaiman K, Al-Motarreb A, Almahmeed W, Asaad N, Amin H, et al. Baseline characteristics, management practices, and long-term outcomes of middle eastern patients in the Second Gulf Registry of Acute Coronary Events (Gulf RACE-2). Ann Saudi Med 2012; 32:9-18.
9. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001; 38:2114-2130.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
11. Forge BH. The 'acute coronary syndromes: consensus recommendations for translating knowledge into action' position statement is based on a false premise. Med J Aust 2010; 192:696-699.
12. Every NR, Parsons LS, Fihn SD, Larson EB, Maynard C, Hallstrom AP, et al. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation 1997; 96:1770-1775.
13. Gabriel Steg P, Iung B, Feldman LJ, Maggioni AP, Keil U, Deckers J, et al. ENACT Investigators. Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT. Eur Heart J 2003; 24:613-622.
14. Rogers WJ, Canto JG, Barron HV, Boscarino JA, Shoultz DA, Every NR. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. J Am Coll Cardiol 2000; 35:371-379.
15. Krumholz HM, Chen J, Murillo JE, Cohen DJ, Radford M. Admission to hospitals with on-site cardiac catheterization facilities: impact on long-term costs and outcomes. Circulation 1998; 98:2010-2016.
16. Alter DA, Naylor CD, Austin PC, Tu JV. Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA 2001; 285:2101-2108.
17. Labarere J, Belle L, Fourny M, Genè s N, Lablanche JM, Blanchard D, et al. Unitede Soins Intendifs Coronaires 2000 Inverstigators. Outcomes of myocardial infarction in hospitals with percutaneous coronary intervention facilities. Arch Intern Med 2007; 167:913-920.
18. Khadour FH, Fu Y, Chang WC, Ma X, Mark D, Granger CB, et al. GUSTOIIb Investigators. Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. Can J Cardiol 2003; 19:257-263.
19. Chen J, Krumholz HM, Wang Y, Curtis JP, Rathore SS, Ross JS, et al. Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med 2010; 170:433-439.
20. Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 2007; 28:1072-1078.
21. Panduranga P, Sulaiman K, Al-Zakwani I, Zubaid M, Rashed W, Al-Mahmeed W, et al. Utilization and determinants of in-hospital cardiac catheterization in patients with acute coronary syndrome from the middle east. Angiology 2010; 61:744-750.
22. Jernberg T, Johanson P, Held C, Svennblad B, Lindback J,Wallentin L, et al. SWEDEHEART/RIKS-HIA. Association between adoption of evidencebased treatment and survival for patients with ST-elevation myocardial infarction. JAMA 2011; 305:1677-1684.
23. Ko DT, Donovan LR, Huynh T, Rinfret S, So DY, Love MP, et al. A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals. Can J Cardiol 2008; 24:839-843.